Indications and uses
Helps prevent sunburn. If used as directed with other sun protection measures (see Directions ), helps decrease the risk of skin cancer and early skin aging caused by the sun.
Super Sensitive Shield
- Manufacturer
- Dermalogica, Inc. | Cosway | Diamond Wipes
- Effective date
- 2017-12-06
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-05-31 22:53:18
Label at a glance#
ProductSuper Sensitive Shield SPF 30
Active ingredientTitanium Dioxide, Zinc Oxide
Label structure10 sections
Dosage and administration
Apply liberally 15 minutes before sun exposure. Reapply at least every two hours Use a water resistant sunscreen if swimming or sweating. Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To help decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including: - limit time in the sun, especi...
Storage and handling
Protect this product from excessive heat and direct sun.
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
Active Ingredients
Titanium Dioxide 7.0%, Zinc Oxide 9.0%.
Purpose
Sunscreen
Uses
- Helps prevent sunburn.
- If used as directed with other sun protection measures (see Directions), helps decrease the risk of skin cancer and early skin aging caused by the sun.
Warnings
For external use only
OTC - DO NOT USE SECTION
Do not use on damaged or broken skin
OTC - WHEN USING SECTION
When using this product keep out of eyes. Rinse with water to remove.
OTC - STOP USE SECTION
Stop use and ask a Doctor if rash occurs.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- Apply liberally 15 minutes before sun exposure.
- Reapply at least every two hours
- Use a water resistant sunscreen if swimming or sweating.
- Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To help decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including:
- limit time in the sun, especially from 10 a.m. – 2 p.m.
- wear long-sleeve shirts, pants, hats and sunglasses.
- Children under 6 months: ask a doctor.
Other information
- Protect this product from excessive heat and direct sun.
Inactive ingredients
Water/Aqua/Eau, Cyclopentasiloxane, Dicaprylyl Ether, Butylene Glycol, Polyglyceryl-3 Polydimethylsiloxyethyl Dimethicone, Lauryl PEG-9 Polydimethylsiloxyethyl Dimethicone, Stearic Acid, Aluminum Hydroxide, Dimethicone, Leuconostoc/Radish Root Ferment Filtrate, Camellia Sinensis Leaf Extract, Avena Sativa (Oat) Kernel Extract, Boerhavia Diffusa Root Extract, Oxothiazolidine, Citrullus Vulgaris (Watermelon) Fruit Extract, Pyrus Malus (Apple) Fruit Extract, Sodium Hyaluronate, Sodium PCA, Sodium Lactate, Lens Esculenta (Lentil) Fruit Extract, Ascorbyl Tetraisopalmitate, Lavandula Spica (Lavender) Flower Oil, Eucalyptus Globulus Leaf Oil, Lavandula Hybrida Oil, Sodium DNA, Tocopherol, Caprylic/Capric Triglyceride, Carbomer, Pentylene Glycol, Hydroxyphenyl Propamidobenzoic Acid, Bisabolol, Zingiber Officinale (Ginger) Fruit Extract, Dimethicone/Vinyl Dimethicone Crosspolymer, Silica, Dipotassium Glycyrrhizate, Triethoxysilylethyl Polydimethylsiloxyethyl Hexyl Dimethicone, Dimethicone/ PEG-10/15 Crosspolymer, PEG/ PPG-18/18 Dimethicone, Glycerin, Cyclomethicone, Tocopheryl Acetate, Disodium EDTA, Sodium Benzoate, Sodium Chloride, Sodium Citrate, Ethylhexylglycerin, Phenoxyethanol.
Questions or comments
Call toll free
1-800-831-5150 in the US.
PRINCIPAL DISPLAY PANEL - 50 mL Bottle Carton
super
sensitive
shield
spf
30
broad
spectrum
NPN# 80031042
UltraCalming™
1.7 US FL OZ
50 mL e
dermalogica®
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 444b3e50-f226-46ef-bfca-2e7035d140cd | Product name | 1 | 20190611 |
| 597b1cfd-7b31-5048-62be-ca5cd740da2f | Product name | 1 | 20140508 |
| ec2149b3-5c6d-5344-f757-c86411073075 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68479-150-00 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-0e0b-a910-e053-dadaa90a0b85 | Super Sensitive Shield SPF 30 |
| 68479-150-01 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-0e0b-a910-e053-dadaa90a0b85 | Super Sensitive Shield SPF 30 |
| 68479-150-02 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-0e0b-a910-e053-dadaa90a0b85 | Super Sensitive Shield SPF 30 |
| 68479-150-04 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-0e0b-a910-e053-dadaa90a0b85 | Super Sensitive Shield SPF 30 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68479-150-00 | Super Sensitive Shield SPF 30 | 2 mL in 1 POUCH | LOTION | 2 | 3 | |
| 68479-150-01 | Super Sensitive Shield SPF 30 | 3 mL in 1 BOTTLE | LOTION | 3 | 3 | |
| 68479-150-02 | Super Sensitive Shield SPF 30 | 50 mL in 1 BOTTLE | LOTION | 50 | 3 | |
| 68479-150-02 | Super Sensitive Shield SPF 30 | 1 in 1 CARTON | LOTION | 1 | 3 | |
| 68479-150-04 | Super Sensitive Shield SPF 30 | 118 mL in 1 BOTTLE | LOTION | 118 | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Titanium Dioxide | ACTIVE INGREDIENT | 15FIX9V2JP | 2 | |
| Zinc Oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 2 | |
| Titanium Dioxide | ACTIVE MOIETY | 15FIX9V2JP | 2 | |
| Zinc Oxide | ACTIVE MOIETY | SOI2LOH54Z | 2 | |
| .Alpha.-Tocopherol Acetate | INACTIVE INGREDIENT | 9E8X80D2L0 | 2 | |
| Aluminum Hydroxide | INACTIVE INGREDIENT | 5QB0T2IUN0 | 2 | |
| Apple | INACTIVE INGREDIENT | B423VGH5S9 | 2 | |
| Ascorbyl Tetraisopalmitate | INACTIVE INGREDIENT | 47143LT58A | 2 | |
| Boerhavia Diffusa Root | INACTIVE INGREDIENT | KR0SR09KYL | 2 | |
| Butylene Glycol | INACTIVE INGREDIENT | 3XUS85K0RA | 2 | |
| Carbomer Homopolymer Type C (Allyl Pentaerythritol Crosslinked) | INACTIVE INGREDIENT | 4Q93RCW27E | 2 | |
| Cyclomethicone | INACTIVE INGREDIENT | NMQ347994Z | 2 | |
| Cyclomethicone 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 2 | |
| Dicaprylyl Ether | INACTIVE INGREDIENT | 77JZM5516Z | 2 | |
| Dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 2 | |
| Dimethicone/Vinyl Dimethicone Crosspolymer (Soft Particle) | INACTIVE INGREDIENT | 9E4CO0W6C5 | 2 | |
| Edetate Disodium | INACTIVE INGREDIENT | 7FLD91C86K | 2 | |
| Ethylhexylglycerin | INACTIVE INGREDIENT | 147D247K3P | 2 | |
| Eucalyptus Oil | INACTIVE INGREDIENT | 2R04ONI662 | 2 | |
| Ginger | INACTIVE INGREDIENT | C5529G5JPQ | 2 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 2 | |
| Glycyrrhizinate Dipotassium | INACTIVE INGREDIENT | CA2Y0FE3FX | 2 | |
| Green Tea Leaf | INACTIVE INGREDIENT | W2ZU1RY8B0 | 2 | |
| Hyaluronate Sodium | INACTIVE INGREDIENT | YSE9PPT4TH | 2 | |
| Hydroxyphenyl Propamidobenzoic Acid | INACTIVE INGREDIENT | 25KRT26H77 | 2 | |
| Lauryl PEG-9 Polydimethylsiloxyethyl Dimethicone | INACTIVE INGREDIENT | 25G622K2RA | 2 | |
| Lavandin Oil | INACTIVE INGREDIENT | 9RES347CKG | 2 | |
| Lavender Oil | INACTIVE INGREDIENT | ZBP1YXW0H8 | 2 | |
| Lens Culinaris Fruit | INACTIVE INGREDIENT | ZYZ076G9JH | 2 | |
| Leuconostoc/Radish Root Ferment Filtrate | INACTIVE INGREDIENT | D2QHA03458 | 2 | |
| Levomenol | INACTIVE INGREDIENT | 24WE03BX2T | 2 | |
| Medium-Chain Triglycerides | INACTIVE INGREDIENT | C9H2L21V7U | 2 | |
| Oat | INACTIVE INGREDIENT | Z6J799EAJK | 2 | |
| Oxothiazolidine | INACTIVE INGREDIENT | M6U1ZG59XD | 2 | |
| PEG/PPG-18/18 Dimethicone | INACTIVE INGREDIENT | 9H0AO7T794 | 2 | |
| Pentylene Glycol | INACTIVE INGREDIENT | 50C1307PZG | 2 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 2 | |
| Silicon Dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 2 | |
| Sodium Benzoate | INACTIVE INGREDIENT | OJ245FE5EU | 2 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | 2 | |
| Sodium Citrate | INACTIVE INGREDIENT | 1Q73Q2JULR | 2 | |
| Sodium Lactate | INACTIVE INGREDIENT | TU7HW0W0QT | 2 | |
| Sodium Pyrrolidone Carboxylate | INACTIVE INGREDIENT | 469OTG57A2 | 2 | |
| Stearic Acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 2 | |
| Tocopherol | INACTIVE INGREDIENT | R0ZB2556P8 | 2 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 2 | |
| Watermelon | INACTIVE INGREDIENT | 231473QB6R | 2 |
Products#
Every source-derived product name is available through these pages.
- Super Sensitive Shield SPF 30
- Titanium Dioxide and Zinc Oxide
- Titanium Dioxide
- Zinc Oxide
- Water
- Cyclomethicone 5
- Dicaprylyl Ether
- Butylene Glycol
- Lauryl PEG-9 Polydimethylsiloxyethyl Dimethicone
- Stearic Acid
- Aluminum Hydroxide
- Dimethicone
- Leuconostoc/Radish Root Ferment Filtrate
- Green Tea Leaf
- Oat
- Boerhavia Diffusa Root
- Oxothiazolidine
- Watermelon
- Apple
- Hyaluronate Sodium
- Sodium Pyrrolidone Carboxylate
- Sodium Lactate
- Lens Culinaris Fruit
- Ascorbyl Tetraisopalmitate
- Lavender Oil
- Eucalyptus Oil
- Lavandin Oil
- Tocopherol
- Medium-Chain Triglycerides
- Carbomer Homopolymer Type C (Allyl Pentaerythritol Crosslinked)
- Pentylene Glycol
- Hydroxyphenyl Propamidobenzoic Acid
- Levomenol
- Ginger
- Dimethicone/Vinyl Dimethicone Crosspolymer (Soft Particle)
- Silicon Dioxide
- Glycyrrhizinate Dipotassium
- PEG/PPG-18/18 Dimethicone
- Glycerin
- Cyclomethicone
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 68479-150 | 68479-150-02, 68479-150-01, 68479-150-04, 68479-150-00 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBCUTANEOUS | 1486 mg | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | FILM / BUCCAL | 1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SUSPENSION / SOFT TISSUE | 1 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | SHAMPOO / TOPICAL | 9.7 %w/w | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRADERMAL | 7 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | CAPSULE / ORAL | 90 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INFILTRATION | 3535 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRACAUDAL | 210 mg | ||
| Medium-Chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | INJECTION, EMULSION / INTRAVENOUS | 1.1 %w/v | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SYRUP / ORAL | 40 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | CAPSULE / ORAL | 6 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | CREAM / TOPICAL | 0.4 %w/w | ||
| Tocopherol | TOCOPHEROL | R0ZB2556P8 | TABLET / ORAL | 0.08 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRATHECAL | 1.35 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | ENEMA / RECTAL | 0.7 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | GEL / TOPICAL | 0.18 %w/w | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, DELAYED RELEASE PARTICLES / ORAL | 170 mg | ||
| Butylene Glycol | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION, EMULSION / INTRAVENOUS | 59 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAVASCULAR | NA | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SUSPENSION / ENDOTRACHEAL | 46.76 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SPRAY / NASAL | 1 mg | ||
| Hyaluronate Sodium | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRA-ARTICULAR | 23 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOAP / TOPICAL | 1.26 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| .Alpha.-Tocopherol Acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg | ||
| Carbomer Homopolymer Type C (Allyl Pentaerythritol Crosslinked) | CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | GEL, METERED / TRANSDERMAL | 50 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | FILM, EXTENDED RELEASE / TRANSDERMAL | 49 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / ORAL | 1126 mg | ||
| Tocopherol | TOCOPHEROL | R0ZB2556P8 | CREAM / TOPICAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| Carbomer Homopolymer Type C (Allyl Pentaerythritol Crosslinked) | CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | GEL / OPHTHALMIC | 4 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / TOPICAL | 210 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 360 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRACAVITARY | 0.82 %w/v | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| PEG/PPG-18/18 Dimethicone | PEG/PPG-18/18 DIMETHICONE | 9H0AO7T794 | GEL / TOPICAL | 1 %w/w | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | DROPS / ORAL | NA | ||
| Medium-Chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | LOTION / TOPICAL | 7 %w/w | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | AEROSOL, FOAM / TOPICAL | 0.05 %w/w | ||
| Cyclomethicone | CYCLOMETHICONE | NMQ347994Z | LOTION / TOPICAL | 3510 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | EMULSION / TOPICAL | NA | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SOLUTION / INTRAVENOUS | 7 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| Cyclomethicone | CYCLOMETHICONE | NMQ347994Z | SOLUTION / TOPICAL | 11.57 %w/v | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | ENEMA / RECTAL | 60 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | CREAM / VAGINAL | 3 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / TOPICAL | 0.32 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / AURICULAR (OTIC) | 18 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, DELAYED RELEASE / ORAL | 1190 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRATUMOR | 1.2 %w/v | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SPRAY / RESPIRATORY (INHALATION) | 0.05 %w/w | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED / ORAL | 3 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| e9be18c5-5b52-4187-9b70-e894fb8c33c9 | a0d544bf-a7f7-49d9-80b5-f8eef1df392b | 2017-12-06 | Warnings | e9be18c5-5b52-4187-9b70-e894fb8c33c9 a0d544bf-a7f7-49d9-80b5-f8eef1df392b |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.